Reach Grant Program Description Significant barriers exist that impede the translation of innovative and important ideas to the clinic. The Reach Grant seeks to remove one of these barriers by providing support for important pre-clinical hypothesis-driven research projects that are necessary to move a study from the preclinical arena into a clinical trial. Thus, the goal of this award is to support translational studies that will result in a phase 1 and/or 2 clinical trial, two to three years from the project end date. Examples of appropriate research projects include but aren’t limited to, completing IND-enabling studies, providing requisite pre-clinical data for clinical trial development, or perhaps through the validation of biomarkers that will enable selection of the correct patients for entry into new clinical trials.

Application Timeline and Review  
• A full proposal must be submitted that meets all guideline criteria as well as all eligibility criteria; otherwise, applications will be administratively rejected.
• Proposals will be reviewed by an independent panel of experts according to the NIH recognized peer-review process. 

Download the guidelines (pdf)